Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Boston Scientific acquires the remainder of Rubicon Medical

Executive Summary

Boston Scientific has exercised its option under a 2003 agreement to acquire the Rubicon Medical (interventional vascular medical devices) shares held by its principal stockholders (chairman David Berger and president and CEO Richard Linder), giving it a 53.6% stake in the company. BS has also agreed to purchase any other remaining outstanding shares; altogether it will pay $71.7mm in cash, with the potential of another $83.7mm in milestone-based earn-outs.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash
    • Includes Contract

Related Companies